Oil Is the New Gold
Health Care: Drugs
Novo Nordisk A/S (NVO: NYSE)
$158.76 -3.11 | -1.92%
06/19/13 - 04:03 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 161.87 |
| 52 Week High | 194.44 |
| 52 Week Low | 135.77 |
| Avg. Daily Vol. (Mil) | 0.25 |
| Beta (3 year) | 1.06 |
| Share Related Items | |
| Mkt Cap (Mil) | 89,028.50 |
| Shares Out (Mil) | 550.00 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 1.40 |
| Annual Dividend | 2.26 |
| Payout Ratio | 31.00 |
| Financial Strength | |
| Quick Ratio | 0.70 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | 22.20 |
| Price/Sales | 6.30 |
| Price/Book | 15.32 |
| Price/Cash Flow | 19.90 |
| Per Share Data | |
| Earnings | 7.30 |
| Sales | 25.70 |
| Book Value | 10.56 |
| Cash Flow | 8.15 |
| Business Summary | |
|---|---|
| Novo-Nordisk A/S is a healthcare company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company operates in two business segments, diabetes care and biopharmaceuticals. | |
| General Information | |
| Novo All
Bagsvrd, 2880 |
|
| www.novonordisk.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 35000 | |
| CEO: Mr. Lars Rebien Sorensen | |
| Short Interest | |
| Current Month (Mil) | 0.64 |
| Previous Month (Mil) | 0.57 |
| Short Interest Ratio (Days) | 2.90 |
| Management Effectiveness | |
| Return on Equity | 68.90 |
| Return on Assets | 37.30 |
| Return on Investments | 68.90 |
| Profitability | |
| Gross Margin | 86.30 |
| EBIT Margin | 38.70 |
| Profit Margin | 28.30 |
Portfolios with NVO
- Portfolio NameUser Type
- ProRenaissance Technologies
- UserMY FAVORITE STOCKS
- ContributorHighest-Yielding Drug Stocks
- ProTom Gayner - Markel Gayner ...
- UserD and B
- Contributor5 Blue-Chip Stocks to Buy
- UserPicks for 2011 (navalier)
- Userkimsh Rate Pension
- UserBesh
- UserAndras Alliance
Latest NVO Headlines from TheStreet
- Novo Nordisk A/S (NVO): Today's Featured Drugs Winner 06.11.13 | 05:06 pm
- 4 Stocks Boosting The Drugs Industry Higher 06.11.13 | 01:06 pm
- Novo Nordisk A/S (NVO): Today's Featured Drugs Winner 06.04.13 | 05:06 pm
- Drugs Stocks On The Rise With Help From 3 Stocks 06.04.13 | 01:06 pm
- NVO Shares Cross Below 200 DMA 05.29.13 | 11:05 am
- NVO, NVS And ACT, Pushing Drugs Industry Downward 05.28.13 | 01:05 pm
- 3 Stocks Improving Performance Of The Health Care Sector 05.06.13 | 01:05 pm
- Novo Nordisk A/S (NVO): Today's Featured Health Care Laggard 05.01.13 | 05:05 pm
- Novo Nordisk A/S Rises On Unusually High Volume (NVO) 04.29.13 | 03:04 pm
- Novo Nordisk A/S (NVO): Today's Featured Health Care Winner 04.24.13 | 05:04 pm
Press Releases for NVO
- Sixty-One Per Cent Of Women Say Their Sex Lives Are Suffering Due To A Condition Of Menopause - PR Newswire 05.06.13 | 05:05 am
- Novo Nordisk Unveils New U.S. Headquarters - PR Newswire 04.19.13 | 12:04 pm
- Novo Nordisk Celebrates 90 Years Of Diabetes Innovation - PR Newswire 02.19.13 | 07:02 am
- Novo Nordisk Promotes Four Members Of U.S. Leadership Team To Senior Vice President - PR Newswire 01.31.13 | 08:01 am
- Global Survey Reveals More Than A Quarter Of Canadians With Type 2 Diabetes Do Not Take Insulin As Prescribed And One Third Are Experiencing Events Of Low Blood Sugar Frequently - PR Newswire 11.28.12 | 08:11 am
- Novo Nordisk To Award $100,000 To Local Programs That Help People Living With Diabetes In Madison And Milwaukee As Part Of Educational Initiative - PR Newswire 09.19.12 | 09:09 am
- Former Miss America Nicole Johnson And NBA Hall-of-Famer Dominique Wilkins To Join Novo Nordisk Employees From Across U.S. For Diabetes Advocacy Day On Capitol Hill - PR Newswire 06.27.12 | 08:06 am
- Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative - PR Newswire 06.26.12 | 08:06 am
- Is There Sexual Intimacy After Menopause? Canadian Women Reveal Greater Need For Physician-Women Dialogue Regarding Vaginal Health - PR Newswire 06.26.12 | 06:06 am
- Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In San Francisco As Part Of Educational Initiative - PR Newswire 06.19.12 | 11:06 am
Partner Headlines for NVO
- The Seeking Alpha Experiment: Portfolio Introduction And 2013 Quarter 1 Review - Seeking Alpha 04.12.13 | 08:04 pm
- Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 21, 2013 - NASDAQ 03.19.13 | 01:03 pm
- Stock Averages Lose Ground As Tiny Cyprus Impacts - Investor's Business Daily 03.18.13 | 04:03 pm
- Stocks Keep Paring Losses; Meritage Homes At New High - Investor's Business Daily 03.18.13 | 03:03 pm
- Stocks Pare Losses In Afternoon; Novo Nordisk Sinks - Investor's Business Daily 03.18.13 | 01:03 pm
- Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises - Investor's Business Daily 02.11.13 | 05:02 pm
- Stocks Little Changed; Ruger Briefly Dips Below Entry - Investor's Business Daily 02.11.13 | 05:02 pm
- Stocks Barely Dip; Starz Takes Off - Investor's Business Daily 02.11.13 | 04:02 pm
- Stocks Hold Mild Losses; LinkedIn Hits New High - Investor's Business Daily 02.11.13 | 02:02 pm
- Stocks Narrow To Thin Red Line; Generac Backslides - Investor's Business Daily 02.11.13 | 12:02 pm
